Beyond the Counter: A Powerful Shift in the Saudi Retail Pharmacy Market

Scale and footprint matter in how the channel evolves. According to Argaam (latest available numbers cited as 2023), total retail pharmacies in Saudi Arabia stood at 10,189. On the demand side, multiple population projections suggest a steadily expanding customer base. Argaam reports Saudi Arabia’s population is expected to grow from 35.3 million in 2024 to 39.8 million by 2030f. Ken Research similarly projects growth from 36 million in 2023 to 40 million by 2030. Meanwhile, consumer spending on healthcare also moved upward, with Ken Research stating it rose from SAR 18 billion in 2018 to SAR 21 billion in 2023, an approximate 17% increase. For retailers, these inputs support broader assortment strategies and higher service expectations.

What Is Driving the Shift Beyond Dispensing?

Demand is being shaped by both lifestyle pressures and therapy mix. ResearchAndMarkets.com cites adult smoking prevalence in Saudi Arabia at 16.5% as of 2024, estimating 4,434,374 adult smokers; it also states 5.0% of young people smoke. In the wider pharmaceutical market, Credence Research reported prescription drugs held 63% share in 2024, compared with OTC drugs at 18%, vaccines at 12%, and dietary supplements at 7%. It also notes branded drugs led with 54% share in 2024, with generics at 36% and biosimilars at 10%. These shares help explain why retail pharmacies are balancing core prescription volume with expanded front-of-store health categories that fit self-care and prevention.

Channel modernization is also becoming a differentiator. Ken Research points to Saudi Arabia’s healthcare transformation plan under Vision 2030, including an aim of privatizing 295 hospitals by 2030 to improve quality and efficiency. That wider system change can influence referral patterns, prescription flows, and patient expectations at the pharmacy counter. On operations, Ken Research notes that in 2022 Nahdi Medical Company launched IMDAD, described as a state-of-the-art Smart Logistics & Distribution Center located to serve the entire Kingdom. Future Market Insights adds that digitalization initiatives are improving supply chain efficiency and patient access, and that strategic partnerships between manufacturers and pharmacy operators are optimizing inventory management and delivery efficiency.

Digital commerce is another practical layer of transformation. ResearchAndMarkets.com describes online pharmacies as offering home delivery, easier access to hard-to-find medications, and a broad range of health products, from OTC drugs to dietary supplements, supported by logistics partnerships and digital payment integration. At the same time, the environment remains tightly controlled. ResearchAndMarkets.com highlights regulatory complexities, noting that the pharmaceutical sector is heavily regulated and that retail pharmacies must comply with a wide range of rules set by the SFDA, varying by product categories such as OTC drugs, prescription medicines, and medical devices. In this context, the Saudi retail pharmacy market is increasingly about compliant convenience, reliable availability, and service design that meets rising expectations.